A joint research team affiliated with UNIST has developed a 3D-printed artificial tumor tissue capable of replicating the in ...

Abstract Heterogeneity and the absence of a tumor microenvironment (TME) in traditional patient-derived organoid (PDO) cultures limit their ...

The tumor microenvironment (TME) is a highly dynamic and heterogeneous network where immune, stromal, and malignant cells interact to modulate cancer progression and immunotherapy outcomes. The ...

High-content imaging-based 3D models advance hematological cancer research with clinically relevant tumor modeling Crown Bioscience, a global contract research organization (CRO) headquartered in ...

The highly heterogeneous nature of PC, its strong immune escape ability and easy metastasis make it the most lethal malignant tumor in the world. With the rapid development of sequencing technology, ...

Researchers from The University of Texas MD Anderson Cancer Center will present promising results from clinical trials in three minisymposia abstracts at the American Association for Cancer Research ...

NEW YORK, April 25, 2025 (GLOBE NEWSWIRE) -- IO Biotech (Nasdaq: IOBT), a clinical-stage biopharmaceutical company developing novel, immune-modulatory, off-the-shelf therapeutic cancer vaccines ...

“This immune suppression mechanism is well-known ... Combining spatial transcriptomics and ECM imaging in 3D for mapping cellular interactions in the tumor microenvironment. cels. 2025. doi: 10.1016/j ...

Dr Olwyn Mahon on how she uses 3D models to understand ... where she developed 3D cancer models and applied spatial multiomics to study extracellular matrix and immune interactions.